Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522

PURPOSE: Combining cisplatin or cetuximab with radiation improves overall survival (OS) of patients with stage III or IV head and neck carcinoma (HNC). Cetuximab plus platinum regimens also increase OS in metastatic HNC. The Radiation Therapy Oncology Group launched a phase III trial to test the hyp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ang, K. Kian, Zhang, Qiang, Rosenthal, David I., Nguyen-Tan, Phuc Felix, Sherman, Eric J., Weber, Randal S., Galvin, James M., Bonner, James A., Harris, Jonathan, El-Naggar, Adel K., Gillison, Maura L., Jordan, Richard C., Konski, Andre A., Thorstad, Wade L., Trotti, Andy, Beitler, Jonathan J., Garden, Adam S., Spanos, William J., Yom, Sue S., Axelrod, Rita S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2014
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4162493/
https://ncbi.nlm.nih.gov/pubmed/25154822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.53.5633
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados